Halozyme Therapeutics (HALO) PT Lowered to $40 at Goldman Sachs

January 18, 2024 5:58 AM EST Send to a Friend
Goldman Sachs analyst Corinne Jenkins ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login